Drugs that contain Spinosad

1. Natroba patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US5496931 PARAPRO LLC Insecticide and miticide A83543 compounds and their method of production by fermentation
Mar, 2013

(11 years ago)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6342482 PARAPRO LLC Formulations for controlling human lice
Jun, 2019

(4 years ago)

US7030095 PARAPRO LLC Pediculicidal and ovacidal treatment compositions and methods for killing head lice and their eggs
Jul, 2021

(2 years ago)

US6063771 PARAPRO LLC Formulations for controlling human lice
Jul, 2023

(8 months ago)

US9895388 PARAPRO LLC Methods and compositions useful for controlling cutaneous mites
Nov, 2033

(9 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Indication(I-858) Apr 28, 2024
M(M-152) Nov 30, 2017
New Chemical Entity Exclusivity(NCE) Jan 18, 2016

NCE-1 date: 18 January, 2015

Market Authorisation Date: 18 January, 2011

Treatment: Topical treatment of head lice infestation in patients four (4) years of age and older; Natroba topical suspension is a pediculicide indicated for the topical treatment of head lice infestation in pat...


More Information on Dosage

NATROBA family patents

Family Patents